379 related articles for article (PubMed ID: 23943032)
1. Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.
Ahmed K; Alhefdhi A; Schneider DF; Ojomo KA; Sippel RS; Chen H; Mazeh H
Ann Surg Oncol; 2013 Dec; 20(13):4200-4. PubMed ID: 23943032
[TBL] [Abstract][Full Text] [Related]
2. Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients.
Rajaei MH; Oltmann SC; Adkisson CD; Elfenbein DM; Chen H; Carty SE; McCoy KL
Surgery; 2014 Oct; 156(4):760-6. PubMed ID: 25239313
[TBL] [Abstract][Full Text] [Related]
3. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
Cayo AK; Sippel RS; Schaefer S; Chen H
Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
[TBL] [Abstract][Full Text] [Related]
4. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
Wachtel H; Cerullo I; Bartlett EK; Kelz RR; Karakousis GC; Fraker DL
Ann Surg Oncol; 2015; 22(6):1781-8. PubMed ID: 25354574
[TBL] [Abstract][Full Text] [Related]
5. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
Mazeh H; Chen H; Leverson G; Sippel RS
Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
[TBL] [Abstract][Full Text] [Related]
6. Does the final intraoperative PTH level really have to fall into the normal range to signify cure?
Reiher AE; Schaefer S; Chen H; Sippel RS
Ann Surg Oncol; 2012 Jun; 19(6):1862-7. PubMed ID: 22203183
[TBL] [Abstract][Full Text] [Related]
7. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
Heller KS; Blumberg SN
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
[TBL] [Abstract][Full Text] [Related]
8. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.
Chiu B; Sturgeon C; Angelos P
Arch Surg; 2006 May; 141(5):483-7; discussion 487-8. PubMed ID: 16702520
[TBL] [Abstract][Full Text] [Related]
9. Focused parathyroidectomy with intraoperative parathyroid hormone monitoring in patients with lithium-associated primary hyperparathyroidism.
Wade TJ; Yen TW; Amin AL; Evans DB; Wilson SD; Wang TS
Surgery; 2013 May; 153(5):718-22. PubMed ID: 23352236
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.
Barczynski M; Konturek A; Cichon S; Hubalewska-Dydejczyk A; Golkowski F; Huszno B
Clin Endocrinol (Oxf); 2007 Jun; 66(6):878-85. PubMed ID: 17437518
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success.
Weber KJ; Misra S; Lee JK; Wilhelm SW; DeCresce R; Prinz RA
Surgery; 2004 Dec; 136(6):1154-9. PubMed ID: 15657570
[TBL] [Abstract][Full Text] [Related]
12. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.
Nilubol N; Weisbrod AB; Weinstein LS; Simonds WF; Jensen RT; Phan GQ; Hughes MS; Libutti SK; Marx S; Kebebew E
World J Surg; 2013 Aug; 37(8):1966-72. PubMed ID: 23722465
[TBL] [Abstract][Full Text] [Related]
13. The additional value of intraoperative parathyroid hormone assessment is marginal in patients with nonfamilial primary hyperparathyroidism: a prospective cohort study.
Twigt BA; van Dalen T; Vollebregt AM; Kortlandt W; Vriens MR; Borel Rinkes IH
Am J Surg; 2012 Jul; 204(1):1-6. PubMed ID: 22192616
[TBL] [Abstract][Full Text] [Related]
14. Intra-operative parathyroid hormone kinetics and influencing factors with high baseline PTH: a prospective study.
Singh DN; Gupta SK; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK; Shukla M; Agarwal A
Clin Endocrinol (Oxf); 2013 Jun; 78(6):935-41. PubMed ID: 23046058
[TBL] [Abstract][Full Text] [Related]
15. Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.
Shawky M; Abdel Aziz T; Morley S; Beale T; Bomanji J; Soromani C; Lam F; Philips I; Matias M; Honour J; Smart J; Kurzawinski TR
Clin Endocrinol (Oxf); 2019 Feb; 90(2):277-284. PubMed ID: 30346646
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism.
Trinh G; Noureldine SI; Russell JO; Agrawal N; Lopez M; Prescott JD; Zeiger MA; Tufano RP
Surgery; 2017 Jan; 161(1):78-86. PubMed ID: 27863787
[TBL] [Abstract][Full Text] [Related]
17. Significance of rebounding parathyroid hormone levels during parathyroidectomy.
Schneider DF; Ojomo KA; Mazeh H; Oltmann SC; Sippel RS; Chen H
J Surg Res; 2013 Sep; 184(1):265-8. PubMed ID: 23669749
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism.
Hughes DT; Miller BS; Doherty GM; Gauger PG
World J Surg; 2011 Feb; 35(2):336-41. PubMed ID: 21153816
[TBL] [Abstract][Full Text] [Related]
19. Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.
Carr AA; Yen TW; Wilson SD; Evans DB; Wang TS
J Surg Res; 2017 Mar; 209():162-167. PubMed ID: 28032553
[TBL] [Abstract][Full Text] [Related]
20. Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement.
Mownah OA; Pafitanis G; Drake WM; Crinnion JN
Ann R Coll Surg Engl; 2015 Nov; 97(8):603-7. PubMed ID: 26492907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
